Prophylactic administration of L-arginine improves the intestinal barrier function after mesenteric ischaemia

Gut

Volumn 39, Issue 2, 1996, Pages 194-198

  Schleiffer, R ^a,b   Raul, F ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b IRCAD   (France)

Author keywords

Intestine; Ischaemia reperfusion; Mucosal barrier permeability; Nitric oxide

Indexed keywords

ARGININE; CYCLIC GMP; MOLSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTESTINE FUNCTION; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

EID: 0029793382     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.2.194     Document Type: Article

References (42)

1. Haglund U, Bulkley GB, Granger DN. On the pathophysiology of intestinal ischemic injury. Clinical review. Acta Chir Scand 1987; 153: 321-4.
2. Granger DN, Sennet M, McElearney PM, Taylor AE. Effect of local arterial hypotension on cat intestinal capillary permeability. Gastroenterology 1980; 79: 474-80.
3. Schoenberg MH, Beger HG. Oxygen radicals in intestinal ischemia and reperfusion, Chem Biol Interact 1990; 76: 141-61.
4. Kubes P. Ischemia-reperfusion in feline small intestine: a role of nitric oxide. Am J Physiol 1993; 264: G143-9.
5. Granger DN, Hollwarth M, Parks DA. Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol Scand 1986; 548: S47-63.
6. Parks DA, Bulkley GB. Granger DN, Hamilton SR, McCord JM. Ischemic injury in the cat small intestine: role of Superoxide radicals, Gastroenterology 1992; 82: 9-15.
7. Johnson LR. Regulation of gastrointestinal mucosa growth. Physiol Rev 1988; 68: 456-502.
8. Otamiri T. Oxygen radicals, lipid peroxidation, and neutrophil infiltration after small-intestinal ischemia and reperfusion. Surgery 1989; 105: 593-7.
9. Kubes P, Kanwar S, Niu X-F, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cell. FASEB J 1993; 7: 1293-9.
10. Nillson U, Lundgren O, Haglind E, Bylund-Fellenius A. Radical production during in vivo intestinal ischemia and reperfusion in the cat. Am J Physiol 1989; 257: G409-14.
11. Hernandez L, Grisham M, Twohig B, Arfors K, Harlan J, Granger DN. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253: H699-703.
12. Brown MF, Ross III AJ, Dasher J, Turley DL, Ziegler MM, O'Neil JA. The role of leukocytes in mediating mucosal injury of intestinal ischemia reperfusion. J Pediatr Surg 1990; 25: 214-7.
13. Schoenberg MH, Poch B, Younes M, Schwarz A, Buczako K, Lundberg C, et al. Involvement of neutrophils in postischemic damage to the small intestine. Gut 1991; 32: 905-12.
14. Otamari T, Lindahl M, Tagesson C. Phospholipase A2 inhibition prevents mucosal damage associated with small intestinal ischemia in rats. Gut: 1988; 29: 489-94.
15. Salzman A, Wollert PS, Wang H, Menconi MJ, Youssef ME, Compton CC, et al. Intraluminal oxygenation ameliorates ischemia-reperfusion-induced gut mucosal hyperpermeability in pigs. Circ Shock 1993; 40: 37-46.
16. Raul F, Galluser M, Schleiffer R, Gosse F, Hasselmann M, Seiler N. Beneficial effects of dietary L-Arginine on intestinal epithelial restitution after ischemic damage in rats, Digestion 1995; 56: 400-5.
17. Payne D, Kubes P. Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 1993; 265: G189-95.
18. Hutcheson IR, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in indotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101: 815-20.
19. MacKendrick W, Caplan M, Hsueh W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury. Paediatr Res 1993; 34: 222-8.
20. Moncada S, Palmer RMJ, Higgs EA. Nitric Oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
21. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthetize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
22. Megison SM, Horton JW, Chao H, Walker PB. A new model for intestinal ischemia in rat. J Surg Res 1990; 49: 168-73.
23. 14C-polyethylene glycol 4000 in intestinal venous blood: influence of osmolarity and laxatives, effect on net water flux determination. Naunyn Schmiedebergs Arch Pharmacol 1982; 321: 149-56.
24. Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem 1964; 7: 18-25.
25. Maroux S, Louvard D, Baratti J. The aminopeptidase from hog intestinal brush border. Biochem Biophys Acta 1973; 321: 282-95.
26. 15 mol level. Anal Biochem 1973; 56: 394-407.
27. Koch B, Lutz-Bucher B. Inhibition of protein kinase C activity in cultured pituitary cells attenuates both cAMP-independent and -dependent secretion of ACTH. Mol Cell Endocrinol 1991; 77: 57-65.
28. Aoki N, Johnson G, Lefer A. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol 1990; 258: G275-81.
29. Gianotti L, Alexander JW, Pyles T, Fukushima R. Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. Ann Surg 1993; 217: 644-54.
30. Madden HP, Breslin RJ, Wasserkrug HL, Efron G, Barbul A. Stimulation of T-cell immunity by arginine enhances survival in peritonitis, J Surg Res 1988; 44: 658-63.
31. Horton JW, Walker PB. Oxygen radicals, lipid peroxidation, and permeability changes after intestinal ischemia and reperfusion. J Appl Physiol 1993; 74: 1515-20.
32. Pizcueta P, Pique JM, Bosch J, Whittle BJR, Moncada S. Effect of inhibition of nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105: 184-90.
33. Iwata F, Joh T, Kawai T, Itoh M. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol 1992; 263: G149-54.
34. Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 1992; 262: G1138-42.
35. Brenner BM, Troy JL, Ballermann BJ. Endothelium-dependent vascular responses. Mediators and mechanisms. J Clin Invest 1989; 84: 1373-8.
36. Kanvar S, Tepperman BL, Payne D, Sutherland LR, Kubes P. Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ Shock 1994; 42: 135-40.
37. Bassenge E, Kukovetz WR, Molsidomine. In: Scriabine A, ed. New drugs annual: cardiovascular drugs. Vol 2. New York: Raven Press, 1984: 177-91.
38. Feelisch M, Noak E. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987; 139: 19-30.
39. Kukovetz W, Holzmann S. Cyclic GMP as the mediator of molsidomine-induced vasodilatation. Eur J Pharmacol 1986; 122: 103-9.
40. Ostrowski J, Resag K. Pharmacokinetics of molsidomine in humans. Am Heart J 1985; 109: 641-3.
41. Kubes P. Nitric oxide-induced microvascular permeability alterations; aregulatory role for cGMP. Am J Physiol 1993; 265: H1909-15.
42. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-58.